Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes

Although advanced bladder cancer overall has a poor prognosis, a subset of patients demonstrate durable response to immune checkpoint inhibitors. Evidence shows that the response to checkpoint inhibitors may be associated with type and degree of immune infiltration in the tumor microenvironment. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huili, Zhang, Qingzhao, Shuman, Lauren, Kaag, Matthew, Raman, Jay D., Merrill, Suzanne, DeGraff, David J., Warrick, Joshua I., Chen, Guoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989654/
https://www.ncbi.nlm.nih.gov/pubmed/31996725
http://dx.doi.org/10.1038/s41598-020-58351-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989654/
https://www.ncbi.nlm.nih.gov/pubmed/31996725
http://dx.doi.org/10.1038/s41598-020-58351-6

Ejemplares similares